C
HAE icon

Covestor’s Haemonetics HAE Stock Holding History

Covestor’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70K Buy
932
+485
+109% +$31.2K 0.04% 584
2026
Q1 		$25K Sell
447
-1,550
-78% -$101K 0.02% 1019
2025
Q4 		$160K Buy
1,997
+1,296
+185% +$87.1K 0.08% 308
2025
Q3 		$34K Sell
701
-376
-35% -$23.3K 0.02% 1072
2025
Q2 		$81K Buy
1,077
+527
+96% +$34.9K 0.05% 670
2025
Q1 		$35K Sell
550
-188
-25% -$12.8K 0.02% 970
2024
Q4 		$58K Buy
738
+439
+147% +$35.3K 0.04% 795
2024
Q3 		$24K Sell
299
-76
-20% -$6.14K 0.02% 1147
2024
Q2 		$31K Sell
375
-300
-44% -$26.4K 0.02% 1041
2024
Q1 		$58K Buy
675
+438
+185% +$34.4K 0.04% 828
2023
Q4 		$20K Sell
237
-164
-41% -$14.2K 0.01% 1200
2023
Q3 		$36K Sell
401
-1
-0.2% -$89 0.03% 899
2023
Q2 		$34K Sell
402
-2
-0.5% -$169 0.03% 935
2023
Q1 		$33K Buy
404
+301
+292% +$24.4K 0.03% 862
2022
Q4 		$8K Buy
103
+99
+2,475% +$7.96K 0.01% 1418
2022
Q3 		$0 Sell
4
-2
-33% -$144 ﹤0.01% 2231
2022
Q2 		$0 Sell
6
-2
-25% -$118 ﹤0.01% 2100
2022
Q1 		$1K Sell
8
-2
-20% -$109 ﹤0.01% 1835
2021
Q4 		$1K Buy
+10
New +$609 ﹤0.01% 1772

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Covestor's HAE Position: Q2 2026 in Review

Covestor increased its Haemonetics (HAE) stake by 109% in Q2 2026, buying an estimated $31.2K and bringing the position to 932 shares worth $70K. The position accounts for 0.04% of the portfolio, ranked #584.

Covestor first reported a position in HAE in Q4 2021 and has held it in 19 quarters since. The position peaked at $160K in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Covestor held 932 shares of Haemonetics worth $70K as of Q2 2026.
  • Covestor bought 485 Haemonetics shares in Q2 2026, an estimated $31.2K.
  • Haemonetics made up 0.04% of Covestor's portfolio in Q2 2026, its #584 holding.
  • Covestor first reported a position in Haemonetics in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Haemonetics position peaked at $160K in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.